GlassScriptPhysician profile
William B Lutes
NPI 1437123080
$1,024,542.59
in general payments reported to CMS, 2019-2025
11 companies · $109K in 2025
The $109K reported for 2025 was more than what 93% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179K · 2020: $51K · 2021: $76K · 2022: $217K · 2023: $160K · 2024: $232K · 2025: $109K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $243K · Royalty Or License: $102K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $76K · Travel and Lodging: $65K · Food and Beverage: $9,692 · Honoraria: $5,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $243,325.64 |
| Royalty Or License | $101,999.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75,809.40 |
| Travel and Lodging | $64,980.48 |
| Food and Beverage | $9,691.88 |
| Honoraria | $5,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $779,097.15 | 2019-2025 | Journey II, Real Intelligence, Tandem |
| Orthalign INC | $241,543.77 | 2019-2025 | Orthalign Plus |
| Globus Medical, INC. | $1,597.05 | 2023-2025 | Proven Gen-Flex Ps Knee System, Onvoy, Actify 3d |
| Encore Medical, LP | $1,469.58 | 2021-2024 | Djo Surgical |
| Linkbio Corp | $271.38 | 2024 | |
| Stryker Corporation | $141.61 | 2023 | Augment Injectable, Inbone, Viaflow |
| Motive Health, INC. | $101.50 | 2019 | |
| Depuy Synthes Sales INC. | $98.88 | 2022-2025 | Attune |
| Corin USA | $83.43 | 2019 | |
| Onkos Surgical, INC. | $77.30 | 2023 | Eleos Limb Salvage System |
| Shalby Advanced Technologies, INC. | $60.94 | 2023 | Unisyn Hip System, Tahoe Uni Knee System, Consensus Knee System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,402,199.21 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lutes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.